Alice Domenichini

基本信息

浏览量：0

职业迁徙

个人简介

Alice Domenichini currently works at the CHIRI, Curtin University. Alice does research as part of the Metabolic Signalling Group. Alice's focus is in Pancreatic Cancer with the aim to identify new metabolic targets and develop new pharmacological therapies. Their most recent publication is 'Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.'

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Pericyte Phenotype Switching Alleviates Immunosuppression and Sensitizes Vascularized Tumors to Immunotherapy in Preclinical Models

Zhi-Jie Li,Bo He,Alice Domenichini, Jiulia Satiaputra, Kira H Wood,Devina D Lakhiani, Abate A Bashaw,Lisa M Nilsson, Ji Li, Edward R Bastow,Anna Johansson-Percival, Elena Denisenko,Alistair Rr Forrest, Suraj Sakaram,Rafael Carretero, Günter J Hämmerling, Jonas A Nilsson, Gabriel Yf Lee,Ruth Ganss

The Journal of clinical investigation（2024）

引用0浏览0WOS引用

ABCC3 is a novel target for the treatment of pancreatic cancer (vol 73, 100634, 2019)

Alice Domenichini

ADVANCES IN BIOLOGICAL REGULATION (2022)

引用0浏览0引用

Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine

Ilaria Casari,Aikaterini Emmanouilidi,Alice Domenichini,Marco Falasca

Advances in Biological Regulation（2022）

引用2浏览0WOS引用

Rhenium N-heterocyclic Carbene Complexes Block Growth of Aggressive Cancers by Inhibiting FGFR- and SRC-mediated Signalling

Alice Domenichini,Ilaria Casari,Peter V. Simpson,Nima Maheshkumar Desai,Lingfeng Chen,Christopher Dustin,Jeanne S. Edmands,Albert van der Vliet,Moosa Mohammadi,Massimiliano Massi,Marco Falasca

Journal of Experimental & Clinical Cancer Researchno. 1 (2020): 1-17

引用15浏览0引用

Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells

Omar Elaskalani,Alice Domenchini,Norbaini Binti Abdol Razak,Danielle E. Dye,Marco Falasca,Pat Metharom

Cancersno. 1 (2020): 250-250

引用28浏览0WOS引用

Additional File 1: of Pharmacological Inhibition of ABCC3 Slows Tumour Progression in Animal Models of Pancreatic Cancer

Aleksandra Adamska,Alice Domenichini, Emily Capone, Verena Damiani, Begum Gokcen Akkaya, Kenneth J. Linton, Pierluigi Di Sebastiano, Xi Chen, Adam B. Keeton, Verónica Ramírez-Alcántara, Yulia Maxuitenko, Gary A. Piazza, Vincenzo De Laurenzi, Gianluca Sala,Marco Falasca

Figshare (2019)

引用0浏览0引用

Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation